Streamlining Psychiatry Prior Authorizations with Cognizant TriZetto

Optimizing Psychiatry Workflows with Cognizant TriZetto

The intersection of psychiatry and a robust clearinghouse like Cognizant TriZetto demands precise and efficient prior authorization management. Klivira enhances this interaction by automating the submission and tracking of PAs for high-volume categories such as atypical antipsychotics, ADHD stimulants, transcranial magnetic stimulation (TMS), and esketamine/ketamine treatments. Our platform ensures that the data required by payers, often routed through TriZetto, is accurately and promptly delivered, minimizing administrative friction.

Common Prior Authorization Triggers in Psychiatry

• Inpatient psychiatric admission and continued stay, often requiring concurrent review with ASAM or InterQual/MCG behavioral criteria.
• Partial hospitalization (PHP) and intensive outpatient (IOP) levels of care.
• Residential treatment for substance use disorder (SUD) and eating disorders.
• Specialty psychiatric medications, including long-acting injectable antipsychotics (e.g., paliperidone palmitate, aripiprazole long-acting) and REMS-restricted drugs like esketamine (Spravato) and brexanolone (Zulresso).
• Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), typically requiring documentation of failed medication trials.
• Ketamine and esketamine clinic treatments, with specific FDA label and payer policy considerations.
• Specialty drugs for tardive dyskinesia (e.g., valbenazine, deutetrabenazine).

Meeting Documentation Requirements for Behavioral Health PAs

Psychiatric prior authorizations rely heavily on established clinical guidelines such as the APA Practice Guidelines and the ASAM Criteria for SUD. Payers commonly require specific documentation, including DSM-5-TR diagnoses, severity scales (e.g., PHQ-9, GAD-7), safety risk assessments, and evidence of prior level-of-care trials. For TMS, documentation of failed antidepressant trials is standard. Klivira's platform is designed to streamline the compilation and submission of this critical clinical data, ensuring compliance with payer-specific requirements often transmitted via the X12 278 transaction set through clearinghouses like TriZetto.

Mitigating Common Prior Authorization Denials in Psychiatry

• ASAM level mismatch, where documented severity does not align with the requested level of care.
• Step therapy denials for TMS or specialty injectables due to insufficient documented prior medication trials.
• Concurrent review denials for continued inpatient or residential stays when severity criteria are no longer met.
• Potential parity-act violations, where payer criteria may appear more restrictive than comparable medical-surgical benefits.
• Denials for out-of-network treatment, particularly for residential SUD care where in-network options are limited.

Klivira's Automation for Psychiatry Prior Authorizations via TriZetto

Klivira's platform provides a comprehensive solution for managing psychiatry prior authorizations through Cognizant TriZetto. Our system integrates directly with your EMR to extract clinical data, applying ASAM-criteria-aware level-of-care logic and flagging potential parity issues. We automate the submission of X12 278 requests to payers via TriZetto and manage the concurrent review workflow for inpatient and residential continued stays. This approach minimizes manual effort, accelerates approval times, and helps maintain continuity of care for mental health and SUD patients.